Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP460802.RA2gVBLYux_lYk9knvMlrjSzI_g13yTEjRKbQx24k2wro130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP460802.RA2gVBLYux_lYk9knvMlrjSzI_g13yTEjRKbQx24k2wro130_assertion type Assertion NP460802.RA2gVBLYux_lYk9knvMlrjSzI_g13yTEjRKbQx24k2wro130_head.
- NP460802.RA2gVBLYux_lYk9knvMlrjSzI_g13yTEjRKbQx24k2wro130_assertion description "[In contrast to gastric cancer cases, alpha(1)-antitrypsin was detected in only 5% of patients (three out of 56) with chronic atrophic gastritis, and the detection frequency went up as the disease developed (one of four intestinal metaplasia cases, two of seven tubular adenoma cases, a single examined case of hyperplastic polyp and 60% of gastric cancer).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP460802.RA2gVBLYux_lYk9knvMlrjSzI_g13yTEjRKbQx24k2wro130_provenance.
- NP460802.RA2gVBLYux_lYk9knvMlrjSzI_g13yTEjRKbQx24k2wro130_assertion evidence source_evidence_literature NP460802.RA2gVBLYux_lYk9knvMlrjSzI_g13yTEjRKbQx24k2wro130_provenance.
- NP460802.RA2gVBLYux_lYk9knvMlrjSzI_g13yTEjRKbQx24k2wro130_assertion SIO_000772 15378737 NP460802.RA2gVBLYux_lYk9knvMlrjSzI_g13yTEjRKbQx24k2wro130_provenance.
- NP460802.RA2gVBLYux_lYk9knvMlrjSzI_g13yTEjRKbQx24k2wro130_assertion wasDerivedFrom befree-2016 NP460802.RA2gVBLYux_lYk9knvMlrjSzI_g13yTEjRKbQx24k2wro130_provenance.
- NP460802.RA2gVBLYux_lYk9knvMlrjSzI_g13yTEjRKbQx24k2wro130_assertion wasGeneratedBy ECO_0000203 NP460802.RA2gVBLYux_lYk9knvMlrjSzI_g13yTEjRKbQx24k2wro130_provenance.